NYSE - Delayed Quote USD

Stryker Corporation (SYK)

Compare
352.82 -7.08 (-1.97%)
At close: October 25 at 4:00 PM EDT
350.18 -2.64 (-0.75%)
After hours: October 25 at 7:30 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Kevin A. Lobo Chairman, CEO & President 5.7M 33.71M 1965
Mr. Glenn S. Boehnlein VP & CFO 2.27M 5.44M 1962
Mr. Viju S. Menon Group President of Global Quality & Operations 1.68M -- 1968
Mr. J. Andrew Pierce Group President of MedSurg & Neurotechnology 2.03M 2.69M 1974
Mr. Spencer S. Stiles Group President of Orthopaedics & Spine 2.02M 2.33M 1977
Mr. William E. Berry Jr. VP & Chief Accounting Officer -- -- 1966
Mr. Robert C. Cohen CTO and VP of Global R&D - Joint Replacement -- -- --
Mr. Alan Douville VP, Chief Information Officer & Chief Information Security Officer -- -- --
Mr. Jason Beach Vice President of Finance & Investor Relations -- -- --
Mr. Robert S. Fletcher VP & Chief Legal Officer 895.89k -- 1971

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
269 385 2600 https://www.stryker.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
52,000

Description

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Corporate Governance

Stryker Corporation’s ISS Governance QualityScore as of October 1, 2024 is 5. The pillar scores are Audit: 6; Board: 4; Shareholder Rights: 6; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 29, 2024 at 8:05 PM UTC

Stryker Corporation Earnings Date

October 31, 2024 at 12:00 AM UTC

Dividend Date

Recent Events

September 30, 2024 at 12:00 AM UTC

Ex-Dividend Date

September 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 5, 2024 at 7:00 PM UTC

at Wells Fargo Healthcare Conference

July 31, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 30, 2024 at 8:30 PM UTC

Q2 2024 Earnings Call

July 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 24, 2024 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 14, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 1, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers